PubMed · 2600992
Ifosfamide encephalopathy.
Abstract
We describe a case of reversible encephalopathy caused by the recently released anticancer drug Ifosfamide. The clinical course, role of EEG in monitoring and predicting encephalopathy, and putative mechanism of neurotoxicity is discussed. Short infusion times and/or prior CNS disease may increase the risk of encephalopathy.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M M Danesh, C M De Giorgio, S R Beydoun, R A Kemp. 1989. Ifosfamide encephalopathy.. https://doi.org/10.3109/15563658908994426
Cite the original work for its findings. Save a collection to share your selection of sources.